Update on the Use of Vonoprazan: A Competitive Acid Blocker

Gastroenterology. 2018 Feb;154(3):462-466. doi: 10.1053/j.gastro.2018.01.018. Epub 2018 Jan 11.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Drug Therapy, Combination
  • Gastric Acid / metabolism
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / metabolism
  • Gastrointestinal Diseases / diagnosis
  • Gastrointestinal Diseases / drug therapy*
  • Gastrointestinal Diseases / physiopathology
  • Gastrointestinal Hemorrhage / diagnosis
  • Gastrointestinal Hemorrhage / prevention & control*
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects*
  • Hemostasis, Endoscopic
  • Humans
  • Hydrogen-Ion Concentration
  • Proton Pump Inhibitors / adverse effects
  • Proton Pump Inhibitors / pharmacokinetics
  • Proton Pump Inhibitors / therapeutic use*
  • Pyrroles / adverse effects
  • Pyrroles / pharmacokinetics
  • Pyrroles / therapeutic use*
  • Sulfonamides / adverse effects
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
  • Anti-Bacterial Agents
  • Proton Pump Inhibitors
  • Pyrroles
  • Sulfonamides